CVS
CVS Health Corporation
Stock
$85.20−0.49 (−0.57%)Close Oct 1, 2026
Income statement
| Line | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $415.1B | $402.1B | $372.8B | $357.8B | $322.5B | $292.1B | $268.7B | $256.8B | $194.6B | $184.8B | $177.5B | $153.3B | $139.4B | $126.8B | $123.1B | $107.1B | $95.8B | $98.2B | $87.5B | $76.3B |
| Cost of revenue | — | — | — | — | — | — | — | — | — | $156.2B | $148.7B | $126.8B | $114.0B | $103.0B | $100.6B | $86.5B | $75.6B | $77.9B | $69.2B | $60.2B |
| Gross profit | — | — | — | — | — | — | — | — | — | $28.5B | $28.9B | $26.5B | $25.4B | $23.8B | $22.5B | $20.6B | $20.2B | $20.4B | $18.3B | $16.1B |
| Operating income | $8.3B | $4.7B | $8.5B | $13.7B | $8.0B | $13.3B | $13.9B | $12.0B | $4.0B | $9.5B | $10.4B | $9.5B | $8.8B | $8.0B | $7.2B | $6.3B | $6.1B | $6.4B | $6.0B | $4.8B |
| Non-operating income | −$2.5B | −$2.5B | −$2.4B | −$2.6B | −$2.1B | −$2.8B | −$4.1B | −$3.0B | −$2.6B | −$1.3B | −$1.7B | −$859M | −$1.1B | −$509M | −$905M | −$584M | −$536M | −$525M | −$509M | −$435M |
| Pretax income | $5.8B | $2.1B | $6.1B | $11.2B | $5.8B | $10.5B | $9.8B | $9.0B | $1.4B | $8.3B | $8.6B | $8.6B | $7.7B | $7.5B | $6.3B | $5.7B | $5.6B | $5.9B | $5.5B | $4.4B |
| Taxes | $897M | $368M | $1.5B | $2.8B | $1.5B | $2.5B | $2.6B | $2.4B | $2.0B | $1.6B | $3.3B | $3.4B | $3.0B | $2.9B | $2.4B | $2.3B | $2.2B | $2.2B | $2.3B | $1.7B |
| Net income | $4.9B | $1.8B | $4.6B | $8.3B | $4.3B | $8.0B | $7.2B | $6.6B | −$594M | $6.6B | $5.3B | $5.2B | $4.6B | $4.6B | $3.9B | $3.5B | $3.4B | $3.7B | $3.2B | $2.6B |
| Diluted EPS | $3.78 | $1.39 | $3.66 | $6.47 | $3.26 | $6.02 | $5.46 | $5.08 | −$0.57 | $6.44 | $4.90 | $4.63 | $3.96 | $3.74 | $3.02 | $2.57 | $2.49 | $2.55 | $2.18 | $1.92 |
| Diluted shares | — | 1.27B | 1.26B | 1.29B | 1.32B | 1.33B | 1.31B | 1.31B | 1.04B | 1.02B | 1.08B | 1.13B | 1.17B | 1.23B | 1.28B | 1.35B | 1.38B | 1.45B | 1.47B | 1.37B |
| Revenue growth | — | +7.8% | +4.2% | +10.9% | +10.4% | +8.7% | +4.6% | +32.0% | +5.3% | +4.1% | +15.8% | +10.0% | +9.9% | +3.0% | +15.0% | +11.8% | −2.5% | +12.3% | +14.6% | — |
| Gross margin | — | — | — | — | — | — | — | — | — | 15.4% | 16.3% | 17.3% | 18.2% | 18.8% | 18.3% | 19.2% | 21.1% | 20.7% | 20.9% | 21.1% |
| Operating margin | 2.0% | 1.2% | 2.3% | 3.8% | 2.5% | 4.6% | 5.2% | 4.7% | 2.1% | 5.2% | 5.8% | 6.2% | 6.3% | 6.3% | 5.9% | 5.9% | 6.4% | 6.5% | 6.9% | 6.3% |
| Net margin | 1.2% | 0.4% | 1.2% | 2.3% | 1.3% | 2.7% | 2.7% | 2.6% | −0.3% | 3.6% | 3.0% | 3.4% | 3.3% | 3.6% | 3.1% | 3.2% | 3.6% | 3.8% | 3.7% | 3.5% |
Cost of revenue, other operating expenses, non-operating income and taxes are the differences between the lines reported around them.